| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.089 | 0.04 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.05 |